Prescriptions have been incorrectly written, interpreted, labeled, and/or filled due to marque name Gestalt principle of organization, overlapping dose intensity (4 mg) and form (tablet), and vino names that may lead to their proximal storehouse.
The FDA emphasizes the differences between the galantamine and glimepiride in full term of initial dosing (4 mg twice daily vs 2 mg once daily), available pad of paper strengths, and pad of paper appearances.
Galantamine is available in path tablets (4 mg, off-white; 8 mg, pink; 12 mg, orange-brown) imprinted with “Janssen” on one side, and G followed by the indefinite quantity strong suit on the other.
Glimepiride is available in flat-faced oblong tablets (1 mg, pink; 2 mg, green; 4 mg, blue) imprinted with “Amaryl” and having notched sides at raise bisect.
To change the potential difference for trade good medicinal drug errors, the FDA recommends that physicians clearly communicate oral and written prescriptions for these two products by spelling out the name of the therapy and publication it clearly.
The FDA likewise recommends that pharmacists situation the two drugs apart from one another on the ledge and advises use of a “shelf talker” to aid in their adaption.
Weapon names should be confirmed on oral and written prescriptions, and patients should be counseled regarding the stigma name, datum, and proper use of each medicament.
October 5, 2007
According to the letter of the alphabet.
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.